Caroline Bradford

Joint Comments to the Consumer Product Safety Commission on the Notice of Proposed Rulemaking: “Safety Standard for Infant Support Cushions”

March 18, 2024: NCHR was one of 6 Consumer Safety groups submitting joint comments to the Consumer Product Safety Commission (CPSC) for its Proposed Rule for Safety Standards for Infant Support Cushions

OTC Birth Control Pill Headed to US Pharmacies: What Your Patients Should Know

Medscape March 14, 2024: What patients should know about OTC birth control pill Opill, which will be available in March 2024. How can we make sure patients know the risks and use it correctly and we point out that patients shouldn’t assume that just because it doesn’t require a prescription doesn’t mean it doesn’t have risks.

Failure of ALS drug puts a spotlight on controversial FDA approvals

Washington Post, March 16, 2024: New study results showing that the ALS drug Relyvrio does not work raises important questions about FDA’s decision to be flexible about approval even when the scientific evidence is lacking. We explain that the pendulum has swung too far and each questionable approval results in more pressure on FDA to make more questionable approvals.

NCHR Provides Testimony at the Presidential Advisory Council Meeting on Combating Antimicrobial Resistance

March 15, 2024: NCHR provided testimony at the Presidential Advisory Council Meeting on Combating Antimicrobial Resistance. We advised that AMR research should move away from using pathogen-specific metrics and focus on patient-centered metrics. This will help to improve our current understanding of the clinical significance of resistant and nonresistant bacterial infections.

NCHR Comment on Classification of Certain Wound Dressings

NCHR supports the proposed FDA rule, which aims to reclassify wound dressings and liquid wound washes containing antimicrobials based on their level of antimicrobial resistance (AMR), with higher-risk products categorized as Class III. This change is crucial for mitigating the public health threat posed by AMR, ensuring the appropriate use of these medical devices, and ultimately improving patient outcomes.